Watson David O. 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 21, 2025
Insider Transaction Report
Form 4
Watson David O.
General Counsel
Transactions
- Sale
Common Stock
2025-01-17$29.96/sh−2,201$65,938→ 105,555 total - Award
Common Stock
2025-01-21+42,762→ 148,317 total
Holdings
- 3,333(indirect: Indirect Owner (Custodial Account for Son))
Common Stock
- 6,667(indirect: By Trust)
Common Stock
- 70,136(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2025.
- [F2]This represents a Restricted Stock Unit award granted on January 21, 2025 that vest 25% annually over four years from grant date subject to continued service.
- [F3]This represents a custodial account held by the reporting person for the sole benefit of his minor son.
- [F4]The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
- [F5]The securities are held by The Watson Education Trust (the "Trust"), for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.